ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.1650
-0.0134 (-7.51%)
At close: Sep 17, 2025
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $1.44 million as of September 17, 2025. Its market cap has decreased by -49.15% in one year.
Market Cap
1.44M
Enterprise Value
1.37M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.17
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 1.44M, a decrease of -98.49%. That is a compound annual growth rate of -68.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 1.44M | -45.68% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
| Feb 10, 2022 | 95.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 359.27M |
| American Oncology Network | 353.52M |